Allylmercaptocaptopril compounds and uses thereof

Details Allylmercaptocaptopril compounds and uses thereof Allylmercaptocaptopril compounds and uses thereof

2007-07-10

2007-07-10

Saeed, Kamal A. (Department: 1626)

Organic compounds -- part of the class 532-570 series

Organic compounds

Heterocyclic carbon compounds containing a hetero ring...

C548S953000, C546S245000, C540S607000

Reexamination Certificate

active

10478396

ABSTRACT:
Compounds which are the reaction product of allicin and ACE-inhibiting compounds are useful in treating hypertension, elevated triglycerides, and elevated insulin.

REFERENCES:
patent: 4046889 (1977-09-01), Ondetti et al.
patent: 4347371 (1982-08-01), Iwao et al.
patent: WO-97/39115 (1997-10-01), None
Elkayam et al, “The Effects of Allicin and Enalapril in Fructose-Induced Hyperinsulinemic Hyperlipidemic Hypertensive Rats”,Am J Hypertens14:377-381 (2001).
Abramovitz et al “Allicin-induced decrease in formation of fatty steaks (atherosclerosis) in mice fed on a cholesterol-rich diet”, Coronary Artery Disease 10 (1999) pp. 515-519.
Aquel et al “Direct relaxant effects of garlic juice on smooth and cardiac muscles” J Ethnopharmoco1 33(1-2) (1991) pp. 13-19.
Auer et al “Hypertension and hyperlipidaemia: garlic helps in mild cases” Br J clin Pract Suppl 69 (1990) pp. 3-6.
Augusti et al “Lipid towering effect of allicin (diallyldisulphide-oxide on long tern feeding to normal rats” Experientia 30 (1979) pp. 369-373.
Banerjee A “Effect of aqueous extract of garlic on arterial blood pressure of normotensive and hypertensive rats” Artery 2 (1979) pp. 369-373.
Carmel et al “A flourimetric assay for angiotensin-I converting enzyme in human serum” Clinica Chimica Acta 93 (1979) pp. 215-220.
Cushman et al “History of the design of captopril and related inhibitors of angiotensin converting enzyme” Hypertension 17 (1991) pp. 589-592.
Eliat et al “Alteration of lipid profile in hyperlipidemic rabbits by allicin, an active constituent of garlic” Coronary Artery Dis 6 (1995) pp. 985-990.
Ehrlich et al “Contribution of nitric oxide to the beneficial effects of enalapril in the fructose-induced hyperinsulinemic rat” Hypertension 28 (1996) pp. 754-757.
Ehrlich et al “Efffect of angiotensin-converting enzyme inhibitors of fructose induced hypertension and hyperinsulinaemia in rats” Clin Exp Pharmocol Physiol 22 (Sup1) (1996) pp. s347-s349.
Foushee et al., “Garlic as a natural agent for the treatment of hypertension: a preliminary” Cytobios 34 (135-36) (1982) pp. 145-152.
Lawson LD in Phytomedicines of Europe: Their Chemistry and Biological Activity (Lawson et al eds.) vol. 691, pp. 176-209, American Chemical Society, Washington (1998).
Malik et al “Hypotensive effect of freeze-dried garlic (Allium sativum) sap in dog” PMA J pak Med Assoc 31 (1981) pp. 12-13.
Materson et al “Angiotensin-converting enzyme inhibitors in hypertension. A dozen years of experience” Arch Intern Med 1544 (1994) pp. 513-523.
Migdalof et al “Captopril: pharmacology, metabolism and disposition” Drug Metab Rev 15 (1984) pp. 841-869.
Miron et al “The mode of action of allicin: its ready permeability through phospholipid membranes may contribute to its biological activity” Biochim Biophys Acta 1463 (2000) pp. 20-30.
Ondetti et al., “Design of specific inhibitors of angiotensin-converting enzyme: new class of orally active antihypertensive agents” Science 196 (1977) pp. 441-444.
Petkov U “Plants with hypotensive, antiatheromatous and coronarodilating action” Am J of Chinese Medicine 7 (1979) pp. 197-236.
Rabinkov et al “The mode of action of allicin: trapping radicals and interaction with thiol containing proteins” Biochim Biophys Acta 1379 (1998) pp. 233-244.
Reaven et al “Sugar-induced hypertension in Sprague-Dawley rats” Am J Hypertens 4 (7 Pt 1) (1991) pp. 610-614.
Ruffin et al “An evaluation of the side effects of garlic as an antihypertensive agent” Cytobios 37 (146) (1983) pp. 85-89.
Thind GS “Angiotensin converting enzyme inhibitors: comparative structure, pharmacokinetics, and pharmacodynamics” Cardiovase Drugs Ther 4 (1990) pp. 199-206.

Affiliated with

Also associated with

Rating

Allylmercaptocaptopril compounds and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Allylmercaptocaptopril compounds and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Allylmercaptocaptopril compounds and uses thereof will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3742983